[Understanding/acceptance of radiotherapy: An ethical dilemma resolved by an ethics of care].

Compréhension/acceptation de la radiothérapie : un dilemme éthique résolu par une éthique de la considération et de la sollicitude.
Autonomie Autonomy Beneficence Bienfaisance Consideration Considération Ethics Radiotherapy Radiothérapie Éthique

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
ISSN: 1769-6658
Titre abrégé: Cancer Radiother
Pays: France
ID NLM: 9711272

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 24 06 2022
accepted: 05 08 2022
medline: 5 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: ppublish

Résumé

Ethical questions are poorly investigated specifically in radiation oncology. The objective of the study was to identify and understand the main ethical issue in radiation oncology. A quantitative analysis was based on the answers to a questionnaire of 200 professionals from 22 radiation oncology departments. The questionnaire mainly aimed to characterize the main ethical issue. A monocentric qualitative analysis was based on semi-structured interviews focused on the main identified ethical issue, carried out with eight technologists, and 20 patients undergoing radiotherapy. The main ethical issue was the understanding and/or acceptance of the treatment by the patients (71 %), which frequently arises (more than once a month) (52 %), and corresponds to an ethical tension between the principles of respect for autonomy and beneficence (the good as viewed by the patient) as defined by Beauchamp and Childress. The technologists, wish the patient to be fully involved in his treatment, with the even possibility of refusing it. However, excluding paternalism and autonomic relentlessness, the technologists have the feeling of acting for the good of the patients by treating them with radiation, even if the patients are not always aware of it, because they are within a situation of vulnerability. If the hierarchy of principles is a compromise alternative, this problem is finally well resolved by the effective implementation of an ethic of consideration and solicitude, restoring the patient capabilities, i.e. the maximum development of his potentialities in his situation of vulnerability. Beyond the legal dimension, patient information is crucial and must consider the specific temporality of the patient. The main ethical issue in radiation oncology is the understanding and/or acceptance of the treatment involving the development of an ethic of consideration and solicitude.

Identifiants

pubmed: 37011968
pii: S1278-3218(23)00002-1
doi: 10.1016/j.canrad.2022.08.005
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

115-125

Informations de copyright

Copyright © 2023 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

R de Crevoisier (R)

Département de radiothérapie, centre Eugène-Marquis, LTSI Inserm 1099, université de Rennes 1, Rennes, France. Electronic address: r.de-crevoisier@rennes.unicancer.fr.

J Leseur (J)

Département de radiothérapie, centre Eugène-Marquis, Rennes, France.

C Bouvet (C)

Département de radiothérapie, centre Eugène-Marquis, Rennes, France.

F Huguet (F)

Service d'oncologie radiothérapie, hôpital Tenon, AP-HP, Sorbonne université, Paris, France.

J-L Lagrange (JL)

Université Paris Est Créteil, Créteil, France.

T Haaser (T)

Service d'oncologie radiothérapie, hôpital Haut-Lévêque, 158435, centre hospitalier universitaire de Bordeaux, Pessac, France; EA 4574 « Sciences, Philosophie, Humanités » université de Bordeaux, université Bordeaux Montaigne, Pessac, France; Comité de protection des personnes Sud-Ouest et Outre-Mer III, service de pharmacologie clinique, hôpital Pellegrin, 158435, centre hospitalier universitaire de Bordeaux, Bordeaux, France.

D Pasquier (D)

Centre Oscar-Lambret, université de Lille, Cristal UMR, 9181, Lille, France.

G Créhange (G)

Département, de radiothérapie oncologie, institut Curie, université PSL, Paris/Saint-Cloud/Orsay, France; Laboratoire d'imagerie translationnelle en oncologie (Lito), U1288 université Paris Saclay/Inserm/Institut Curie, Orsay, France; Centre de protonthérapie, institut Curie, université PSL, Orsay, France.

S Supiot (S)

Département de radiothérapie, Institut de cancérologie de l'Ouest, René-Gauducheau, Saint-Herblain, France.

P Pommier (P)

Service de radiothérapie, centre Léon-Bérard, Lyon, France.

A Roy (A)

Département de radiothérapie, centre Eugène-Marquis, Rennes, France.

A Berna (A)

Département de radiothérapie, centre Eugène-Marquis, Rennes, France.

P Blanchard (P)

Service de radiothérapie oncologie, Gustave-Roussy, Paris Saclay University, Oncostat U1018, Inserm, Villejuif, France.

L Marcucci (L)

Faculté de médecine et centre atlantique de philosophie, université Rennes 1, Rennes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH